Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There have been many comorbidities identified in EB patients; the most commonly seen are anemia, infections, osteopenia, failure to thrive, renal disease, squamous cell carcinoma, and cardiomyopathy. Physicians caring for EB patients should be aware of all these complications, initially to prevent some of these from developing by establishing preventive measures and secondly to monitor closely and identify early signs and symptoms of these complications for better clinical outcomes.

Cite

CITATION STYLE

APA

Lara-Corrales, I., Bruckner, A. L., Salas Alanis, J. C., Mellerio, J. E., Pallison, F., & Murrell, D. F. (2015). Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy. In Blistering Diseases: Clinical Features, Pathogenesis, Treatment (pp. 667–685). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_71

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free